abstract |
The present invention relates, in general, to human immunodeficiency virus- ! (HIV- 1), and, in particular to a vaccine for HiV-l and to methods of making and using same. The present invention provides synthetic glycosylated HIV-1 peptides, method for their preparation and use. |